Literature DB >> 31545680

Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort of Linked Electronic Health Records: A CALIBER Study.

Lydia J Leon1,2, Fergus P McCarthy1,3, Kenan Direk2, Arturo Gonzalez-Izquierdo2, David Prieto-Merino2,4, Juan P Casas5, Lucy Chappell1.   

Abstract

BACKGROUND: The associations between pregnancy hypertensive disorders and common cardiovascular disorders have not been investigated at scale in a contemporaneous population. We aimed to investigate the association between preeclampsia, hypertensive disorders of pregnancy, and subsequent diagnosis of 12 different cardiovascular disorders.
METHODS: We used linked electronic health records from 1997 to 2016 to recreate a UK population-based cohort of 1.3 million women, mean age at delivery 28 years, with nearly 1.9 million completed pregnancies. We used multivariable Cox models to determine the associations between hypertensive disorders of pregnancy, and preeclampsia alone (term and preterm), with 12 cardiovascular disorders in addition to chronic hypertension. We estimated the cumulative incidence of a composite end point of any cardiovascular disorder according to preeclampsia exposure.
RESULTS: During the 20-year study period, 18 624 incident cardiovascular disorders were observed, 65% of which had occurred in women under 40 years. Compared to women without hypertension in pregnancy, women who had 1 or more pregnancies affected by preeclampsia had a hazard ratio of 1.9 (95% confidence interval 1.53-2.35) for any stroke, 1.67 (1.54-1.81) for cardiac atherosclerotic events, 1.82 (1.34-2.46) for peripheral events, 2.13 (1.64-2.76) for heart failure, 1.73 (1.38-2.16) for atrial fibrillation, 2.12 (1.49-2.99) for cardiovascular deaths, and 4.47 (4.32-4.62) for chronic hypertension. Differences in cumulative incidence curves, according to preeclampsia status, were apparent within 1 year of the first index pregnancy. Similar patterns of association were observed for hypertensive disorders of pregnancy, while preterm preeclampsia conferred slightly further elevated risks.
CONCLUSIONS: Hypertensive disorders of pregnancy, including preeclampsia, have a similar pattern of increased risk across all 12 cardiovascular disorders and chronic hypertension, and the impact was evident soon after pregnancy. Hypertensive disorders of pregnancy should be considered as a natural screening tool for cardiovascular events, enabling cardiovascular risk prevention through national initiatives.

Entities:  

Keywords:  cardiovascular diseases; hypertension; hypertension, pregnancy-induced; preeclampsia; pregnancy

Mesh:

Year:  2019        PMID: 31545680     DOI: 10.1161/CIRCULATIONAHA.118.038080

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  49 in total

Review 1.  Comparative risks and predictors of preeclamptic pregnancy in the Eastern, Western and developing world.

Authors:  Ning Zhang; Jing Tan; HaiFeng Yang; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2020-09-25       Impact factor: 5.858

2.  Postnatal Enalapril to Improve Cardiovascular Function Following Preterm Preeclampsia (PICk-UP):: A Randomized Double-Blind Placebo-Controlled Feasibility Trial.

Authors:  Laura Ormesher; Suzanne Higson; Matthew Luckie; Stephen A Roberts; Heather Glossop; Andrew Trafford; Elizabeth Cottrell; Edward D Johnstone; Jenny E Myers
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

3.  Heart Failure in Women With Hypertensive Disorders of Pregnancy: Insights From the Cardiovascular Disease in Norway Project.

Authors:  Michael C Honigberg; Hilde Kristin Refvik Riise; Anne Kjersti Daltveit; Grethe S Tell; Gerhard Sulo; Jannicke Igland; Kari Klungsøyr; Nandita S Scott; Malissa J Wood; Pradeep Natarajan; Janet W Rich-Edwards
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

4.  Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Heather A Drummond; Babbette LaMarca; Michael J Ryan; Joey P Granger
Journal:  Compr Physiol       Date:  2020-12-09       Impact factor: 9.090

Review 5.  Preeclampsia and Neurodevelopmental Outcomes: Potential Pathogenic Roles for Inflammation and Oxidative Stress?

Authors:  Aaron Barron; Cathal M McCarthy; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2021-01-25       Impact factor: 5.590

Review 6.  Current Updates on Pre-eclampsia: Maternal and Foetal Cardiovascular Diseases Predilection, Science or Myth? : Future cardiovascular disease risks in mother and child following pre-eclampsia.

Authors:  Samson A Odukoya; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2021-03-10       Impact factor: 5.369

Review 7.  The Role of Sex-Specific Risk Factors in the Risk Assessment of Atherosclerotic Cardiovascular Disease for Primary Prevention in Women.

Authors:  Priya M Freaney; Sadiya S Khan; Donald M Lloyd-Jones; Neil J Stone
Journal:  Curr Atheroscler Rep       Date:  2020-07-16       Impact factor: 5.113

Review 8.  Updates in Diagnosis and Management of Preeclampsia in Women with CKD.

Authors:  Kate Wiles; Lucy C Chappell; Liz Lightstone; Kate Bramham
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-02       Impact factor: 8.237

9.  Cardiovascular Health After Preeclampsia: Patient and Provider Perspective.

Authors:  Ellen W Seely; Ann C Celi; Jaimie Chausmer; Cornelia Graves; Sarah Kilpatrick; Jacinda M Nicklas; Mary L Rosser; Kathryn M Rexrode; Jennifer J Stuart; Eleni Tsigas; Jennifer Voelker; Carolyn Zelop; Janet W Rich-Edwards
Journal:  J Womens Health (Larchmt)       Date:  2020-09-28       Impact factor: 2.681

Review 10.  Role of exosomal microRNA signatures: An emerging factor in preeclampsia-mediated cardiovascular disease.

Authors:  Saravanakumar Murugesan; Lakshmi Saravanakumar; Mark F Powell; Namakkal Soorappan Rajasekaran; Ramaswamy Kannappan; Dan E Berkowitz
Journal:  Placenta       Date:  2020-10-28       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.